Better Therapeutics Statistics

Total Valuation

BTTX has a market cap or net worth of $16,355. The enterprise value is $7.73 million.

Market Cap	16,355
Enterprise Value	7.73M

Important Dates

The last earnings date was Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

BTTX has 54.52 million shares outstanding. The number of shares has increased by 62.47% in one year.

Shares Outstanding	54.52M
Shares Change (YoY)	+62.47%
Shares Change (QoQ)	+23.32%
Owned by Insiders (%)	48.23%
Owned by Institutions (%)	0.21%
Float	24.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.57

Current Ratio	0.57
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-34.95

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-294.47%
Return on Capital (ROIC)	-677.64%
Revenue Per Employee	n/a
Profits Per Employee	-$584,685
Employee Count	54
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BTTX has paid $9,000 in taxes.

Income Tax	9,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.96% in the last 52 weeks. The beta is 2.05, so BTTX's price volatility has been higher than the market average.

Beta (5Y)	2.05
52-Week Price Change	-99.96%
50-Day Moving Average	0.01
200-Day Moving Average	0.12
Relative Strength Index (RSI)	30.02
Average Volume (20 Days)	448,652

Short Selling Information

The latest short interest is 2.13 million, so 3.90% of the outstanding shares have been sold short.

Short Interest	2.13M
Short Previous Month	1.99M
Short % of Shares Out	3.90%
Short % of Float	8.68%
Short Ratio (days to cover)	0.94

Income Statement

Revenue	n/a
Gross Profit	-3.11M
Operating Income	-29.61M
Pretax Income	-31.56M
Net Income	-31.57M
EBITDA	-28.82M
EBIT	-31.93M
Earnings Per Share (EPS)	-$1.15

Full Income Statement

Balance Sheet

The company has $6.60 million in cash and $14.31 million in debt, giving a net cash position of -$7.71 million or -$0.14 per share.

Cash & Cash Equivalents	6.60M
Total Debt	14.31M
Net Cash	-7.71M
Net Cash Per Share	-$0.14
Equity (Book Value)	-9.94M
Book Value Per Share	-0.18
Working Capital	-5.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$26.08 million and capital expenditures -$1.39 million, giving a free cash flow of -$27.47 million.

Operating Cash Flow	-26.08M
Capital Expenditures	-1.39M
Free Cash Flow	-27.47M
FCF Per Share	-$0.71

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BTTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-62.47%
Shareholder Yield	-62.47%
Earnings Yield	-193,048.00%
FCF Yield	-167,973.10%

Analyst Forecast

The average price target for BTTX is $6.00, which is 1,999,900.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	1,999,900.00%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2